13th week of 2009 patent applcation highlights part 48 |
Patent application number | Title | Published |
20090082410 | CONSTITUTIVELY TRANSLOCATING CELL LINE - The present invention relates to agonist-independent methods of screening for compounds that alter GPCR desensitization. Included in the present invention are cell lines containing GRKs, in which GPCRs are desensitized in the absence of agonist; the GRKs may be modified. The present invention relates to methods to determine if a GPCR is expressed at the plasma membrane, and if the GPCR has an affinity for arrestin. Modified GPCRs which have increased arrestin affinity are included in the present invention. These modified GPCRs are useful in methods to screen for compounds that alter desensitization, including both the agonist-independent methods and agonist-dependent methods described herein. | 2009-03-26 |
20090082411 | Pharmaceutical for prevention or treatment of bone metabolic disease - A method for treating a bone metabolic disease by administering to a human a pharmacologically effective amount of an angiotensin II receptor antagonist which is a compound of the following formula (I), a pharmacologically acceptable salt thereof or a pharmacologically acceptable ester thereof: | 2009-03-26 |
20090082412 | DEUTERIUM-ENRICHED DEFERASIROX - The present application describes deuterium-enriched deferasirox, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082413 | DEUTERIUM-ENRICHED LETROZOLE - The present application describes deuterium-enriched letrozole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082414 | DEUTERIUM-ENRICHED VIRAMIDINE - The present application describes deuterium-enriched viramidine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082415 | Topical treatment of cataracts in dogs - The topical treatment of cataracts in dogs is a composition having an aldose reductase inhibitor (ARI) in a topical carrier. The ARI is preferably 2R,4S-6-fluoro-2-methyl-spiro[chroman-4,4′-imidazolidine]-2′,5′-dione, referred to as 2R-methyl sorbinil, having the structure: | 2009-03-26 |
20090082416 | DEUTERIUM-ENRICHED BENDAMUSTINE - The present application describes deuterium-enriched bendamustine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082417 | DEUTERIUM-ENRICHED SDX-101 - The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082418 | DEUTERIUM-ENRICHED FLUVASTATIN - The present application describes deuterium-enriched fluvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082419 | DEUTERIUM-ENRICHED TEGASEROD - The present application describes deuterium-enriched tegaserod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082420 | DEUTERIUM-ENRICHED VILDAGLIPTIN - The present application describes deuterium-enriched vildagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082421 | Crystalline Form B4 of Atorvastatin Magnesium and a Process Thereof - Crystalline polymorphic form B4 of Atorvastatin magnesium of FIG. | 2009-03-26 |
20090082422 | DEUTERIUM-ENRICHED LEVETIRACETAM - The present application describes deuterium-enriched levetiracetam, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082423 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS - Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases. | 2009-03-26 |
20090082424 | SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS - The present invention relates to naturally occurring and chemically synthesized small molecule antagonists of Bcl-2 family proteins. In particular, the present invention provides gossypol compounds (e.g., isomers, enantiomers, racemic compounds, metabolites, derivatives, pharmaceutically acceptable salts, in combination with acids or bases, and the like) and methods of using these compounds as antagonists of the anti-apoptotic effects of Bcl-2 family member proteins (e.g., Bcl-2, Bcl-X | 2009-03-26 |
20090082425 | COMPOUNDS FROM MYROTHECIUM SP. FOR INHIBITING THE GROWTH OF CANCER CELLS - The present invention relates to a tumor-inhibiting compound, in particular to verrucarin A and verrucarin J isolated from | 2009-03-26 |
20090082426 | DIMERS OF ARTEMISININ DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The present invention relates to dimers of artemisinin derivatives, to processes for the preparation of such dimers, to methods of treatment comprising administration of such dimers, and to intermediates to such dimers. | 2009-03-26 |
20090082427 | Composition comprising wortmannin and its topical use for reducing human hair growth - A cosmetic and therapeutic method for reducing human hair growth comprises selecting an area of skin from which reduced hair growth is desired and applying to the area of skin a composition comprising wortmannin in an amount effective to reduce hair growth. | 2009-03-26 |
20090082428 | SPIROKETALS - The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative disorders and anti inflammatory disorders. The spiroketal compounds are also useful as immunosuppressive agents, and also in methods of controlling pests. | 2009-03-26 |
20090082429 | Antimicrobial Compositions and Methods of Use - A catechin is modified in at least one position (most preferably in the 3-position of the C-ring) to increase its lipophilicity. Contemplated catechins are demonstrated to have significantly improved antibacterial properties, likely due to catastrophic membrane damage. | 2009-03-26 |
20090082430 | Materials and Methods for Treating Coagulation Disorders - The subject invention provides anticoagulant compounds of formula I: | 2009-03-26 |
20090082431 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF - The present invention provides compounds that function as modulators of mitochondrial aldehyde dehydrogenase-2 (ALDH2) activity; and pharmaceutical compositions comprising the compounds. The present invention provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition. The present invention further provides assays for identifying agonists of ALDH2. | 2009-03-26 |
20090082432 | DEUTERIUM-ENRICHED RAMELTEON - The present application describes deuterium-enriched ramelteon, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082433 | PREVENTATIVE TREATMENT AND REMISSION OF ALLERGIC DISEASES - The invention provides the use of at least one plant selected from plants of the family Zingiberaceae in the preparation of a medicament for use in the treatment or prophylaxis of allergic diseases. The plant is optionally selected from the genera | 2009-03-26 |
20090082434 | Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same - Compounds of Formula 1 or pharmaceutically acceptable salts thereof are provided: | 2009-03-26 |
20090082435 | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders - Methods, compositions, and compounds for inhibiting monoacyglycerol lipase, and for treating pain, for modulating stress-induced analgesia or for treating stress-induced disorders in mammals are provided. | 2009-03-26 |
20090082436 | DEUTERIUM-ENRICHED RIVASTIGMINE - The present application describes deuterium-enriched rivastigmine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082437 | Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer - The present invention relates to a method for enhancing radiosensitivity in radiotherapy of cervical cancer by administering to cervical cancer cells an effective amount of oxaliplatin. Radiation combined with pretreatment of oxaliplatin according to the present invention helps to enhance the cytotoxicity of radiation and result in augmenting radiation-induced mitotic catastrophe. The analysis on molecular mechanism revealed that oxaliplatin augmented the radiation-induced DNA double-strand break indicated by reducing gamma-H2AX expression, abrogated radiation-induced ATM phosphorylation and reduced the Chk2 phosphorylation. Oxaliplatin can be used as a promising radiosensitizer for treatment of cervical cancer in radiotherapy. | 2009-03-26 |
20090082438 | Coordination Compound Composed of Diaminocyclohexane Platinum (II) and Block Copolymer and Anti-Cancer Agent Comprising the Same - The invention discloses a coordination compound comprising (1,2-diaminocyclohexane)platinum (II) moiety and poly(ethylene glycol)-block-poly(glutamic acid) copolymer moiety; and its use as an anti-cancer agent. The characteristic feature lies in the use of a copolymer whose poly(glutamic acid) segment has a chain length consisting of, on an average, less than 35 repeating units. | 2009-03-26 |
20090082439 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS - An organic light-emitting device adapted for coating and having good emission efficiency and luminance. The organic light-emitting device employs an anode, a cathode, and a layer including an organic compound sandwiched between the anode and cathode. The layer containing the organic compound includes a bisfluorene compound represented by General Formula [1] below. | 2009-03-26 |
20090082440 | SIMPLE PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE - Pantoic acid ester neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enhanced oral bioavailability and methods of using acamprosate prodrugs to treat neurodegenerative disorders, psychotic disorders, mood disorders, anxiety disorders, somatoform disorders, movement disorders, substance abuse disorders, binge eating disorder, cortical spreading depression related disorders, tinnitus, sleeping disorders, multiple sclerosis, and pain are disclosed. | 2009-03-26 |
20090082441 | DEUTERIUM-ENRICHED TESAGLITAZAR - The present application describes deuterium-enriched tesaglitazar, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082442 | DEUTERIUM-ENRICHED LUBIPROSTONE - The present application describes deuterium-enriched lubiprostone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082443 | Use of fatty acid esters of glycerol combined with polylysine against gram-negative bacteria - The present invention relates to a method for the prevention and/or reduction of the presence, growth and/or activity of gram-negative bacteria comprising application of a composition comprising glycerol-based fatty acid esters and polylysine and/or salts of polylysine, wherein said glycerol-based fatty acid ester is used as antibacterial agent. The present invention further relates to the use of said composition as antibacterial agent in various products and applications ranging from technical products and personal-care products to food and drink products for animals and human consumption. | 2009-03-26 |
20090082444 | Compositions for the Treatment of Blood Disorders - The invention relates to compositions containing chemical compounds and compositions containing steel factor which stimulate the expression of hemoglobin or globin protein such as embryonic or fetal globin, or the proliferation of hemoglobin expressing and other cells. These compositions can be used to treat or prevent the symptoms associated with anemia, sickle cell diseases, thalassemia and other blood disorders. The invention also relates to methods for administering these compositions to patients and to medical aids for the treatment and prevention of blood and other disorders. | 2009-03-26 |
20090082445 | GOSSYPOL CO-CRYSTALS AND THE USE THEREOF - This invention relates to compositions comprising co-crystals of (−)-gossypol with a C | 2009-03-26 |
20090082446 | Use of Hydroxyoleic acid and related compounds in the manufacture of drugs - Use of hydroxyoleic acid and its analogous compounds in the manufacture of drugs. Describes the use of hydroxyoleic acid and its analogs of general formula I: COOH—CHR—(CH | 2009-03-26 |
20090082447 | Pharmaceutical Compositions Containing Omega 3 Fatty Acids - Pharmaceutical composition comprising a liquid oil rich in omega-3 polyunsaturated fatty acids which is absorbed on a silica-type support. The composition so obtained has the characteristics of a powder when the oil:silica ratio is of the order of 3:1 while at the same time allowing the required daily dose of omega-3 fatty acids to be delivered in one or more unit doses. The composition according to the invention can be used in the manufacture of oral pharmaceutical forms such as hard capsules. | 2009-03-26 |
20090082448 | METHOD FOR PLACENTAL EXFOLIATION USING OXO-ARACHIDONIC ACID OR THE LIKE - A composition for placental exfoliation and a method for placental exfoliation. The composition for placental exfoliation contains an arachidonic acid derivative or the like, and the method for placental exfoliation comprises the step of administering an arachidonic acid derivative or the like to a mammal after the fetal delivery. | 2009-03-26 |
20090082449 | Spray-Drying Process for Producing a Dry Caritine Powder or Granulate - A process for preparing a dry substantially pure and/or technical carnitine powder or granulate, from a substantially unpurified starting material containing a carnitine compound. | 2009-03-26 |
20090082450 | DEUTERIUM-ENRICHED DICLOFENAC - The present application describes deuterium-enriched diclofenac, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082451 | USE OF THYROID HORMONE CONVERSION INHIBITORS - The present invention is directed to the use of thyroid hormone conversion inhibitors to treat hyperproliferative skin disorders, preferably their use in topical admixtures. | 2009-03-26 |
20090082452 | DEUTERIUM-ENRICHED LUMIRACOXIB - The present application describes deuterium-enriched lumiracoxib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082453 | Exogenous Methyl Dihydrojasmonate for Prevention and Control of Biotic Attack in Plants - Formulations and methods for treating and preventing biotic attack, including disease and insect infestation, in plants are disclosed. The formulations include methyl dihydrojasmonate: | 2009-03-26 |
20090082454 | DEUTERIUM-ENRICHED DISUFENTON - The present application describes deuterium-enriched disufenton, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082455 | THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE - An agent for the prevention, treatment and/or inhibition of progression of an ophthalmic disease and an agent for the protection of an optic nerve, each of which comprises (2R)-2-propyloctanoic acid or a salt or prodrug thereof in which an amount per dose is from 0.3 ng to 5000 mg. The agents are useful for an ophthalmic disease, such as glaucoma, cataract, retinal detachment, muscae volitantes, age-related macular degeneration, diabetic retinopathy, macular edema, myopia, asthenopia, dry eye, amaurosis fugax, choked disc, papillitis optica, retrobulbar neuritis, toxic amblyopia, optic atrophy, higher visual pathway lesion, internuclear opthalmoplegia, gaze palsy and ischemic optic neuropathy. | 2009-03-26 |
20090082456 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS - Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases. | 2009-03-26 |
20090082457 | DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK - This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases. | 2009-03-26 |
20090082458 | DEUTERIUM-ENRICHED ALISKIREN - The present application describes deuterium-enriched aliskiren, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082459 | DEUTERIUM-ENRICHED GUANFACINE - The present application describes deuterium-enriched guanfacine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082460 | Polyamide-Polyether Block Copolymer - Copolymers having linked internal polyether blocks and internal polyamide blocks have advantageous physical properties and solvent-gelling abilities. The copolymer may be prepared from a reaction mixture that contains 1,4-cyclohexane dicarboxylic acid (CHDA) and poly(alkyleneoxy)diamine (PAODA). Optionally, the reaction mixture contains no monofunctional compound reactive with either amine or carboxylic acid groups, however some of this monofunctional compound may be present. Dimer diamine and/or dimer acid may be present in the reaction mixture. A copolymer may also be prepared from a reaction mixture containing dimer acid and at least two diamine compound(s) including PAODA and short-chain aliphatic diamine having 2-6 carbons (SDA), wherein: a) the reaction mixture comprises x grams of PAODA and y grams of SDA, and x/(x+y) is 0.8-0.98; b) the reaction mixture weighs z grams, and x/z is at least 0.25; and c) the reaction mixture contains either no co-diacid, or comprises a small amount of co-diacid, wherein, if the reaction mixture comprises a small amount of co-diacid, then acid equivalents from co-diacid contribute less than 25% of the total acid equivalents present in the reaction mixture. | 2009-03-26 |
20090082461 | DEUTERIUM-ENRICHED MODAFINIL - The present application describes deuterium-enriched modafinil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082462 | DEUTERIUM-ENRICHED ARMODAFINIL - The present application describes deuterium-enriched amodafinil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082463 | N-substituted phenylacetamide derivative and pharmaceutical composition containing the same - The invention provides the following compound (I): | 2009-03-26 |
20090082464 | EXTERNALLY MASKED NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE - Masked nitrogen-substituted and oxygen-substituted neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enhanced oral bioavailability and methods of using acamprosate prodrugs to treat neurodegenerative disorders, psychotic disorders, mood disorders, anxiety disorders, somatoform disorders, movement disorders, substance abuse disorders, binge eating disorder, cortical spreading depression related disorders, tinnitus, sleeping disorders, multiple sclerosis, and pain are disclosed. | 2009-03-26 |
20090082465 | DEUTERIUM-ENRICHED LISDEXAMFETAMINE - The present application describes deuterium-enriched lisdexamfetamine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082466 | Abuse Resistant and Extended Release Formulations and Method of Use Thereof - The present invention is in the field of oral, abuse resistant pharmaceutical compositions of opioids, extended release pharmaceutical compositions of opioids and extended release abuse resistant pharmaceutical compositions of opioids and the use thereof for the treatment of pain. The present invention is also directed to extended release pharmaceutical compositions and the use thereof for preventing or minimizing the risk of opioid abuse and/or opioid toxicity from either intentional or unintentional tampering. The present invention is further directed at a method of preventing or minimizing the risk of opioid abuse and/or opioid toxicity from either intentional or unintentional tampering. | 2009-03-26 |
20090082467 | TREATMENT OF MIGRAINE HEADACHES USING ANTIESTROGENS - A method of preventing the occurrence of migraine headaches in a patient who is a previous sufferer of migraine headaches comprises administering an effective amount therefor of an antiestrogen to the patient for a period of time and sufficiently far in advance of the occurrence of a migraine headache to prevent the development of the prodromal phase of the migraine headache. | 2009-03-26 |
20090082468 | DEUTERIUM-ENRICHED LEVALBUTEROL - The present application describes deuterium-enriched levalbuterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082469 | DEUTERIUM-ENRICHED TERBINAFINE - The present application describes deuterium-enriched terbinafine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082470 | STAT3 INHIBITING COMPOSITIONS AND METHODS | 2009-03-26 |
20090082471 | DEUTERIUM-ENRICHED FINGOLIMOD - The present application describes deuterium-enriched fingolimod, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-03-26 |
20090082472 | HAND SANITIZER AND METHOD OF PREPARATION - A sanitizing composition or hand gel composition having a blend of SDA and Isopropyl Alcohol to kill germs and bacteria, a thickener, such as an acrylic polymer, a stabilizer or polymer acrylic acid neutralizer, such as polyoxyethylene (15) coconut alkylamine, octyl isononanoate as an emollient, glycerin as an additional moisturizer, water, and optionally fragrance or other additives. | 2009-03-26 |
20090082473 | Composition comprising resveratol and its topical use thereof for reducing human hair growth - A cosmetic and therapeutic method for reducing human hair growth comprises selecting an area of skin from which reduced hair growth is desired and applying to the area of skin a composition comprising resveratrol in an amount effective to reduce hair growth. | 2009-03-26 |
20090082474 | HIGHLY DISPERSIBLE CARBON NANOSPHERES IN A POLAR SOLVENT AND METHODS FOR MAKING SAME - The particle sizes of agglomerates of carbon nanospheres are reduced by dispersing the carbon nanospheres in a polar solvent. The carbon nanospheres are multi-walled, hollow, graphitic structures with an average diameter in a range from about 10 nm to about 200 nm, more preferably about 20 nm to about 100 nm. Spectral data shows that prior to being dispersed, the carbon nanospheres are agglomerated into clusters that range in size from 500 nm to 5 microns. The clusters of nanospheres are reduced in size by dispersing the carbon nanospheres in the polar solvent (e.g., water) using a surface modifying agent (e.g., glucose) and ultrasonication. The combination of polar solvent, surface modifying agent, and ultrasonication breaks up and disperses agglomerates of carbon nanospheres. | 2009-03-26 |
20090082475 | PROCESS FOR DEVULCANIZATION OF RUBBER - A process for devulcanization of vulcanized rubber, comprising the steps of: (a) preparing a mixture comprising: between about 5% w/w and about 50% w/w of thermoplastic polymer, between about 49% w/w and about 94% w/w of waste vulcanized rubber, and between about 0.01% w/w and about 1.8% w/w of stabilizing agent; and (b) kneading and desulfurizing the mixture by means of a co-rotating twin screw extruder at an extrusion temperature of between 150° C. and 320° C. to obtain devulcanized rubber. The devulcanized rubber is water-cooled, ground and dried or is rolled into sheet. This process combines the devulcanization, milling process and filtrating rubber as one process, possesses a higher devulcanization efficiency, treatment capability and lower energy consumption. Through the present invention, a controllable devulcanization process and a higher performance of the reformed materials with reclaimed rubber are achieved. | 2009-03-26 |
20090082476 | Method of separation and cleaning of post consumer carpet face yarn from carpet backing yarn product produced therefrom - A process for producing a synthetic fiber composition with reclaimed post consumer carpet yam, wherein face yam is shaved from post consumer carpet using a shaving device to provide shaved face yam, the shaved face yam is reduced in size, contaminants are removed using mechanical screeners, the shave face yam is melt filtered, and then fiber spun. | 2009-03-26 |
20090082477 | CELLULAR ELASTOMER COMPOSITIONS - The present invention provides a polymer composition having a low water absorption and a chlorine content of not greater than 0.5% based on the total weight of the polymer composition. A process for preparing a polymer composition is also provided. | 2009-03-26 |
20090082478 | AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,3,3-PENTAFLUOROPROPANE AND HYDROCARBONS - Methods of preparing polyurethane and polyisocyanurate foams comprising the step of reacting and foaming a mixture of ingredients which react to form the polyurethane or polyisocyanurate foams in the presence of a blowing agent, wherein said blowing agent comprises an azeotrope-like composition consists essentially of 1,1,1,3,3-pentafluoropropane and n-pentane, as well as foams and foamable compositions comprising the azeotrope-like composition. | 2009-03-26 |
20090082479 | FUSED AEROGEL-POLYMER COMPOSITE, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME - Disclosed herein is a method of preparing a fused aerogel-polymer composite in which aerogel and an organic polymer is mixed in a dry state to adsorb polymer particles on the surface of the aerogel and are then subjected to thermal treatment, thus forming a polymer coating on the aerogel. The fused aerogel-polymer composite can be used for thermal insulation in a variety of applications. The fused aerogel-polymer composite exhibits high thermal insulation properties and superior physical strength and processability while still maintaining the properties of an aerogel that does not have a polymer coated on its surface. | 2009-03-26 |
20090082480 | POLYMERIC BINDING MATERIALS - A monomer having a pair of hydroxy groups held in a fixed relationship (e.g. a dihydroxybenzene) is diesterified with a compound having a polymerisable group, e.g. to form a diacrylate. After polymerisation with a crosslinker, the polymer is hydrolysed. The dihydroxy-monomer is removed, leaving a polymer with pair of carboxyl groups held in spatial relationships determined by the dihydroxy monomer. Thus a range of subtly different polymers can be prepared by using different dihydroxy-monomer templates. The polymers are desirably swellable. They can be used as selective binding materials, e.g. in chromatography or analysis. | 2009-03-26 |
20090082481 | Preparation of liquid isocyanurate-modified polymethylene bis(phenylisocyanate) compositions of controlled viscosities - Disclosed is a method for the production of highly stable, liquid isocyanurate-modified PMDI compositions having relatively higher viscosity and a generally comparable functionality, as compared to conventional PMDI. An admixture of the isocyanurate-modified PMDI with conventional PMDI is suitable for use in the manufacture of a variety of polyurethane products, including rigid and flexible foams, coatings, elastomers and sealants. Foams produced using this admixture exhibit properties that are comparable to foams produced from standard polymeric MDI of comparable viscosity that don't contain isocyanurate moieties. | 2009-03-26 |
20090082482 | Storage stable polyol blends containing n-pentane - A storage stable polyol composition composed of at least 25% by weight of a polyol derived from a natural oil and a blowing agent composition which includes greater than 50% by weight of n-pentane. | 2009-03-26 |
20090082483 | POLYGLYCEROL BASED POLYOLS AND POLYURETHANES AND METHODS FOR PRODUCING POLYOLS AND POLYURETHANES - A new class of polyols derived from renewable resources, including polyglycerol and vegetable oils, the use of such polyols in polyurethane foams and cast resins, and methods for making the polyols and polyurethanes are provided. | 2009-03-26 |
20090082484 | Process for producing extruded polyhydroxyalkanoate resin foam - A process for producing an extruded foam of a poly(3-hydroxyalkanoate) (P3HA) yielded from a microorganism. The foam has a high expansion ratio and a high open cell rate and is excellent in environmental compatibility and biodegradability. The process for producing an extruded P3HA resin foam comprises melt-kneading a P3HA together with a volatile foaming agent to produce a mixture and extruding the mixture through a molding die into a low-pressure region, and is characterized in that the resin temperature To at the time when the mixture of a P3HA and a volatile foaming agent is extruded from the extruder (resin temperature measured at the extruder ejection opening with a thermocouple) is in the range shown by the following relationship. | 2009-03-26 |
20090082485 | UV Curable Coating Composition - The invention provides an isocyanate free UV curable hot melt composition which may be hardened upon exposure to UV radiation to provide a protective coating. The coating is particularly useful in wood-working and furniture applications. | 2009-03-26 |
20090082486 | AMPHIPHILIC BLOCK COPOLYMER-TOUGHENED EPOXY RESINS - A curable epoxy resin composition including (a) a thermosettable epoxy resin; and (b) an amphiphilic block copolymer containing at least one epoxy resin miscible block segment and at least one epoxy resin immiscible block segment; wherein the immiscible block segment comprises at least one polyether structure provided that the polyether structure of said immiscible block segment contains at least one or more alkylene oxide monomer units having at least four carbon atoms, such that when the epoxy resin composition is cured, the toughness of the resulting cured epoxy resin composition is increased. The amphiphilic block copolymer is preferably an all polyether block copolymer such as a PEO-PBO diblock copolymer or a PEO-PBO-PEO triblock copolymer. | 2009-03-26 |
20090082487 | PIGMENT DISPERSION COMPOSITION, PHOTOCURABLE COMPOSITION AND COLOR FILTER - There is provided a pigment dispersion composition having high pigment dispersibility and dispersion stability and favorable color characteristics even when containing a high concentration of pigment; a photocurable composition superior in developability and pixel surface smoothness, allowing high contrast; and a color filter having high contrast. | 2009-03-26 |
20090082488 | CURABLE COMPOSITION, ADHESIVE COMPOSITION CONTAINING SUCH CURABLE COMPOSITION, AND ADHESIVE - The present invention has its object to provide an acrylic curable composition which is improved in tackiness, retention and other adhesive properties without reducing the thermal stability and weather resistance. The above-mentioned object can be solved by
| 2009-03-26 |
20090082489 | Phase change ink compositions - A phase change ink composition including (a) an ink vehicle; (b) a dispersing agent; (c) a colorant; and (d) organic fiber shaped nanowhiskers, inorganic fiber shaped nanowhiskers, or a combination of organic and inorganic fiber shaped nanowhiskers, wherein the organic fiber shaped nanowhiskers, the inorganic fiber shaped nanowhiskers, or a combination thereof, are encapsulated or functionalized to enhance compatibility with the ink vehicle; and wherein the colorant and the organic fiber shaped nanowhiskers, the inorganic fiber shaped nanowhiskers, or combination of organic and inorganic fiber shaped nanowhiskers are substantially resistant to aggregation and settling in the ink vehicle. | 2009-03-26 |
20090082490 | SYNTHESIS OF ELASTOMERIC POLY(CARBORANE-SILOXANE-ACETELYENE)S - A linear polymer comprising carborane, siloxane, and acetylene units, which may be cross-linked to a cured polymer and/or pyrolyzed to a ceramic. | 2009-03-26 |
20090082491 | ENVIRONMENTALLY DEGRADABLE POLYMERIC BLEND AND PROCESS FOR OBTAINING AN ENVIRONMENTALLY DEGRADABLE POLYMERIC BLEND - The present invention refers to an environmentally degradable polymeric blend, comprising biodegradable polymers defined by polyhydroxybutyrate (PHB) or copolymers thereof and Polycaprolactone (PCL) and, optionally, at least one additive defined by a filler, nucleant, thermal stabilizer, processing aid, with the purpose of preparing an environmentally degradable polymeric blend. According to the production process described herein, the blend resulting from the mixture of the biodegradable polymers, PHB and PCL, and at least one additive, can be utilized in the manufacture of injected food packages, injected packages for cosmetics, tubes, technical pieces and several injected products. | 2009-03-26 |
20090082492 | Tire with Component Containing Cellulose - The present invention is directed to a pneumatic tire comprising at least one component, the at least one component comprising a rubber composition comprising a diene based elastomer, from 1 to 30 parts by weight per 100 parts by weight of diene based elastomer (phr) of cellulose fiber, and from 1 to 20 phr of a substituted polyisoprene comprising units of formula I, wherein —R comprises hydrogen and one substituent group of structure II | 2009-03-26 |
20090082493 | STABILIZED WATER-BORNE POLYMER COMPOSITIONS FOR USE AS WATER-BASED COATINGS - Stable water-borne polymer compositions are disclosed. The compositions comprise a water-borne polymer, a metal cross-linking agent and a stabilizing agent comprising from 2 to 10 carbon atoms and at least two functional groups independently selected from hydroxy and carboxy. The stabilizing agent is present a 1.4 mole percent or more of the amount of metal cross-linking agent. Inventive compositions are particularly suitable for use in water-based inks and coatings. Methods of making and using the coating compositions are also described. | 2009-03-26 |
20090082494 | Flame retardant compositions - Polymer compositions are afforded flame retardancy with the incorporation of a combination of melamine polyphosphate and poly(m-phenylene methylphosphonate). The polymer compositions are for instance epoxy resins for prepegs, laminates and printed circuit boards. The epoxy resins are for example for coating electronic parts. The polymer compositions are also thermoplastics such as polyolefins or polystyrenics, useful as fibers, films or molded parts. The melamine polyphosphate may be of a fine particle size. | 2009-03-26 |
20090082495 | Pneumatic Tire - The present invention relates to a pneumatic tire having a component comprising at least one elastomer containing olefinic unsaturation; and compound of formula I | 2009-03-26 |
20090082496 | Polymeric composition suitable for manufacturing heat sealable films or sheets - A polymeric composition suitable for manufacturing heat sealable films or sheets comprising, polyethylene terephthalate (PET) to the extent of about 80% to 95% by mass of the total composition; a polymer additive for lowering the melting point of the composition selected from Polyethylene Naphthalate (PEN), Polytrimethylene Naphthalate (PTN), in-situ formed Polyethylene Naphthalate (PEN) and in situ formed Polytrimethylene Naphthalate (PTN) to the extent of about 20% to 5% by mass of the total composition; a nucleating agent to the extent of about 200 to 1500 ppm by mass of the composition; a polycondensation catalyst to the extent of about 30 to 300 ppm by mass of the composition; a clear fast reheat (CFRH) additive to the extent of about 10 to 30 ppm by mass of the composition; a color toner to the extent of about 0.75 to 25 ppm by mass of the composition; and a heat stabilizer to the extent of about 20 to 55 ppm by mass of the composition. | 2009-03-26 |
20090082497 | HIGH CTI POLY(ARYLENE ETHER) COMPOSITION - Disclosed herein is a thermoplastic composition comprising: a poly(arylene ether); a poly(alkenyl aromatic) resin, an organophosphate ester flame retardant, and tricalcium phosphate. The composition may further comprise a reinforcing filler, black pigment, or combination thereof. | 2009-03-26 |
20090082498 | ROOM TEMPERATURE CURABLE ORGANOPOLYSILOXANE COMPOSITION - A room temperature curable organopolysiloxane composition is provided. This composition comprises
| 2009-03-26 |
20090082499 | ALIPHATIC POLYESTER-BASED RESIN REFLECTIVE FILM AND REFLECTIVE PLATE | 2009-03-26 |
20090082500 | MODIFIED THERMALLY EXPANDABLE GRAPHITE AND MATERIAL CONTAINING THE SAME - A modified thermally expandable graphite includes a reaction product of an expandable graphite that contains an intercalation compound intercalated among lattice layers of the expandable graphite, and a silicon-containing organic compound that has at least one alkoxyl group and a reactive group subjected to reaction with the intercalation compound. A sol-gel reaction product of the modified thermally expandable graphite and a modified thermosetting polymeric precursor is also disclosed. | 2009-03-26 |
20090082501 | Polymer made from organosilane compound and boron compound - A novel polymer comprising a reaction product obtained by reacting an organosilane compound with a boron compound. The polymer comprises a reaction product obtained by reacting (a) an aminated silane compound represented by the formula R | 2009-03-26 |
20090082502 | METALLIZED POLYHEDRAL OLIGOMERIC SILSESQUIOXANES AS CATALYSTS FOR POLYURETHANES - A method of using metallized polyhedral oligomeric silsesquioxanes as cure promoters and catalysts for polyurethanes. | 2009-03-26 |
20090082503 | INKJET INK, METHOD OF PRODUCING THE SAME, AND INK SET - The invention provides a method of producing an inkjet ink, the method including at least subjecting a polymer particle dispersion liquid to centrifuge processing, and mixing the polymer particle dispersion liquid that has been subjected to the centrifuge processing and a water-insoluble coloring particle dispersion liquid, as well as an ink set including the produced inkjet ink and a processing liquid that causes the ink to aggregate. | 2009-03-26 |
20090082504 | ROOM TEMPERATURE CURABLE ORGANOPOLYSILOXANE COMPOSITION - A room temperature curable organopolysiloxane composition comprising (A) a diorganopolysiloxane endcapped at both ends of the molecular chain with hydroxy group (HO—(R | 2009-03-26 |
20090082505 | Water Based Pipeline Primer - A water based primer and a method for protecting iron or steel materials against corrosion by first priming with a water borne primer composition containing a) a binder of one or more acrylic copolymers based on one or more acrylic monomers and one or more chlorinated monomers, b) a corrosion inhibiting pigment, c) one or more further pigments, d) optionally conventional additives and/or adjuvants, and e) water and then coating with a bituminous material. Contrary to the current primers on organic solvent basis the water borne primer gives low to no emission of volatile organic compounds (VOCs) and still fulfils the requirements for anti-corrosive effect, cohesive and adhesive strength. | 2009-03-26 |
20090082506 | Single-Constituent Polyorganosiloxane Composition Crosslinkable By Condensation And Comprising A Filler - The invention concerns a single-constituent polycondensation polyorganosiloxane composition comprising a filler. The invention concerns single-constituent polyorganosiloxane (POS) compositions storage-stable in the absence of humidity and crosslinkable, in the presence of water, into elastomer, compositions comprising at least one crosslinkable linear polyorganopolysiloxane POS, a filler and a crosslinking catalyst, the POS having alkoxy, oxime, acyl and/or enoxy, preferably alkoxy, ends, and the composition being essentially free of hydroxylated POS at the ends and the catalyst comprising a vanadium compound and a titanium compound. | 2009-03-26 |
20090082507 | GOLF BALL MATERIAL, GOLF BALL, AND METHOD FOR PREPARING GOLF BALL MATERIAL - The present invention provides a golf ball material made of an ionomer blend composition of (a) at least one E/X copolymer and/or E/X/Y terpolymer and (b) at least one polyfunctional higher aliphatic acid with two or more functionalities that has a molecular weight of at least about 200 but less than about 1,500, in which components (a) and (b) are neutralized with (c) an oxygen-containing inorganic metal compound. The copolymer and terpolymer of component (a) is one or a mixture of two or more selected from the group consisting of copolymers and terpolymers which is partially neutralized with metal ions, copolymers and terpolymers which are completely neutralized with metal ions, and unneutralized copolymers and terpolymers. The golf ball material has a good thermal stability, flow properties and moldability, making it suitable for injection molding. The material is ideal for forming high-performance golf balls of excellent durability, scuff resistance and optimal hardness, without any loss in the rebound resilience of moldings obtained therefrom. | 2009-03-26 |
20090082508 | METHOD FOR OBTAINING PRECIPITATED CALCIUM CARBONATE PARTICLES OF NANOMETRIC SCALE STRUCTURE - Process for the production of precipitated calcium carbonate particles, structured at the nanoscale, by carbonation of milk of lime in the presence of a crystallization controller selected from the following list: polyaspartic acid, dioctyl sodium sulphosuccinate, polyacrylic acid, the molecular weight of which is between 500 and 15 000, and citric acid. When the crystallization controller is citric acid, its concentration in the milk of lime is between 5 and 15%. | 2009-03-26 |
20090082509 | Propylene Polymer Composition - A propylene polymer composition having a high impact strength and a high stiffness for the manufacture of parts having an excellent surface quality comprising
| 2009-03-26 |